Genetic Engineering News Reports on Vaccine Strategies and UBDF Announces 3:1 Split and Stem Cell Initiative.

0 Comments | M2 Presswire, January, 2005

M2 PRESSWIRE-14 January 2005-FNWU: Genetic Engineering News Reports on Vaccine Strategies and UBDF Announces 3:1 Split and Stem Cell Initiative(C)1994-2005 M2 COMMUNICATIONS LTD RDATE:01142005 City of Industry, CA - Biotechnology industry news provided by Financial News USA (OTC: FNWU).

Genetic Engineering News recently reported that R&D efforts on a variety of other vaccine targets are moving along briskly despite the flu vaccine shortage in the U.S. late last year. GenVec (NASDAQ: GNVC) is developing a multiclade adenoviral vector-based vaccine against HIV. The company is working with the Vaccine Research Center of the NIH to create novel adenoviral vectors that encode for multiclade and multigene HIV antigens. Companies covered in complete report...

Premium Content Partnership | HighBeam Research provides an in-depth online archive library of reference works. HighBeam Research

 

BNET TalkbackShare your ideas and expertise on this topic

Please add your comment:

  1. You are currently: a Guest |
  2.  

Basic HTML tags that work in comments are: bold (<b></b>), italic (<i></i>), underline (<u></u>), and hyperlink (<a href></a)